Quince Therapeutics (QNCX) Stock Chart & Stock Price History → The only financial event in 2024 that matters (From Porter & Company) (Ad) Free QNCX Stock Alerts $0.83 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Quince Therapeutics Stock Price Performance5 Day Performance-2.34%1 Month Performance-16.45%3 Month Performance-35.16%6 Month Performance-13.54%Year-To-Date Performance-20.95%1 Year Performance-41.96% Receive QNCX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Quince Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. QNCX Stock Chart for Sunday, June, 2, 2024 QNCX Chart by TradingView Quince Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$0.83$0.83-0.28%$0.88$0.8329,873 shs$35.87 million05/30/2024$0.86$0.83-3.22%$0.85$0.8350,177 shs$35.97 million05/29/2024$0.84$0.86+2.38%$0.88$0.848,595 shs$37.17 million05/28/2024$0.85$0.84-1.16%$0.85$0.8353,007 shs$36.31 million05/27/2024$0.85$0.85$0.87$0.8492,100 shs$36.73 million05/24/2024$0.87$0.85-2.31%$0.87$0.8491,981 shs$36.73 million Get the Latest News and Ratings for QNCX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Quince Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$0.89$0.87-2.50%$0.92$0.86126,906 shs$37.60 million05/22/2024$0.86$0.89+3.76%$0.97$0.86226,460 shs$38.56 million05/21/2024$0.90$0.86-4.42%$0.89$0.86266,876 shs$37.17 million05/20/2024$0.91$0.90-0.57%$0.93$0.88163,078 shs$38.89 million05/17/2024$0.92$0.91-1.62%$0.97$0.90227,283 shs$39.11 million05/16/2024$0.91$0.92+1.31%$0.93$0.9023,939 shs$39.76 million05/15/2024$0.91$0.91-0.22%$0.94$0.9076,264 shs$39.24 million05/14/2024$0.92$0.91-1.05%$1.00$0.90242,718 shs$39.33 million05/13/2024$0.95$0.92-3.19%$0.95$0.9059,191 shs$39.75 million05/10/2024$0.92$0.95+3.26%$0.96$0.90134,198 shs$41.05 million05/09/2024$0.91$0.92+1.10%$0.94$0.9041,972 shs$39.76 million05/08/2024$0.92$0.91-1.09%$0.93$0.90168,976 shs$39.33 million05/07/2024$0.96$0.92-4.17%$0.99$0.90193,863 shs$39.76 million05/06/2024$0.99$0.96-2.55%$0.99$0.9257,847 shs$41.49 million05/03/2024$0.96$0.99+2.61%$0.99$0.9249,208 shs$42.58 million05/02/2024$0.99$0.96-3.36%$1.07$0.93104,589 shs$41.49 million05/01/2024$1.07$0.99-7.16%$1.08$0.9949,001 shs$42.94 million04/30/2024$1.06$1.07+1.42%$1.12$1.0596,565 shs$46.25 million04/29/2024$1.06$1.06-0.47%$1.10$1.0525,698 shs$45.60 million04/26/2024$1.03$1.06+2.91%$1.08$0.98120,416 shs$45.81 million04/25/2024$1.06$1.03-2.83%$1.08$1.0393,060 shs$44.52 million04/24/2024$1.11$1.06-4.50%$1.12$1.0591,171 shs$45.81 million04/23/2024$1.06$1.11+4.72%$1.11$1.04129,357 shs$47.97 million04/22/2024$1.05$1.06+0.95%$1.10$1.0157,633 shs$45.81 million04/19/2024$1.06$1.05-0.94%$1.07$1.0297,247 shs$45.38 million04/18/2024$1.00$1.06+6.00%$1.07$0.9880,573 shs$43.22 million04/17/2024$1.00$1.00+0.35%$1.02$0.96107,929 shs$43.22 million04/16/2024$1.01$1.00-0.85%$1.02$0.95306,189 shs$43.07 million04/15/2024$0.94$1.01+6.59%$1.05$0.9576,138 shs$43.44 million04/12/2024$1.00$0.94-5.71%$0.99$0.89328,300 shs$40.75 million04/11/2024$0.99$1.00+1.01%$1.07$0.9774,828 shs$43.22 million04/10/2024$1.07$0.99-7.48%$1.05$0.9984,422 shs$42.79 million04/09/2024$1.04$1.07+2.88%$1.08$1.0117,476 shs$46.24 million04/08/2024$1.03$1.04+1.46%$1.05$1.0118,739 shs$44.95 millionThis military-backed stock “owns” AI market (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry.04/05/2024$1.04$1.03-1.44%$1.06$1.0195,293 shs$44.30 million04/04/2024$1.05$1.04-0.95%$1.04$1.0144,995 shs$44.58 million04/03/2024$1.05$1.05$1.06$1.0231,217 shs$45.01 million04/02/2024$1.09$1.05-3.67%$1.11$1.0351,435 shs$45.01 million04/01/2024$1.06$1.09+2.83%$1.14$1.05109,138 shs$46.73 million03/29/2024$1.06$1.06$1.13$1.0551,834 shs$45.44 million03/28/2024$1.13$1.06-6.19%$1.13$1.0551,744 shs$45.44 million03/27/2024$1.13$1.13$1.16$1.0660,549 shs$48.44 million03/26/2024$1.20$1.13-5.83%$1.25$1.1266,905 shs$48.44 million03/25/2024$1.20$1.20$1.21$1.1819,763 shs$51.44 million03/22/2024$1.17$1.20+2.56%$1.22$1.1816,298 shs$51.44 million03/21/2024$1.15$1.17+1.74%$1.23$1.1437,737 shs$50.16 million03/20/2024$1.21$1.15-4.96%$1.21$1.1536,844 shs$49.30 million03/19/2024$1.19$1.21+1.68%$1.23$1.1636,418 shs$51.01 million03/18/2024$1.16$1.19+2.59%$1.25$1.1459,267 shs$51.02 million03/15/2024$1.16$1.16$1.23$1.1422,862 shs$49.73 million03/14/2024$1.18$1.16-1.69%$1.19$1.149,864 shs$49.73 million03/13/2024$1.20$1.18-1.67%$1.25$1.1558,807 shs$50.59 million03/12/2024$1.17$1.20+2.56%$1.23$1.1764,834 shs$51.44 million03/11/2024$1.17$1.17+0.43%$1.24$1.1423,004 shs$50.16 million03/08/2024$1.16$1.17+0.43%$1.23$1.0862,743 shs$49.94 million03/07/2024$1.17$1.16-0.85%$1.25$1.1440,440 shs$49.73 million03/06/2024$1.21$1.17-3.31%$1.27$1.1718,541 shs$50.16 million03/05/2024$1.17$1.21+3.42%$1.22$1.1627,090 shs$51.87 million03/04/2024$1.28$1.17-8.59%$1.28$1.1654,382 shs$50.16 million03/01/2024$1.30$1.28-1.54%$1.33$1.2593,515 shs$54.87 million02/29/2024$1.34$1.30-2.99%$1.37$1.3057,085 shs$55.73 million Related Companies: Verastem Stock Price Chart Vistagen Therapeutics Stock Price Chart JATT Acquisition Stock Price Chart Molecular Partners Stock Price Chart Sangamo Therapeutics Stock Price Chart Vigil Neuroscience Stock Price Chart aTyr Pharma Stock Price Chart Omega Therapeutics Stock Price Chart DBV Technologies Stock Price Chart bluebird bio Stock Price Chart Receive QNCX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Quince Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:QNCX) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quince Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.